INVESTINGNovartis, U.K. National Health Service Partner for Trial of Cholesterol-Drug CandidateBy Tony Owusu
MERGERS AND ACQUISITIONSEli Lilly to Buy Skin Treatment Company Dermira for $1.1 BillionBy Joseph Woelfel
INVESTINGBristol-Myers, Gilead, Biogen, Other Drugmakers Increased U.S. List Prices on Jan. 1: ReportBy Rob Lenihan
INVESTINGAstraZeneca and Merck Are Cleared by FDA to Market Treatment for Pancreatic CancerBy Rob Daniel
INVESTINGJohnson & Johnson's Tremfya Plaque-Psoriasis Treatment Is Cleared by China for ImportBy Rob Lenihan
INVESTINGSpectrum Pharma Shares Slump After Lung-Cancer Drug Doesn't Meet Phase II EndpointBy Scott Van Voorhis
INVESTINGEli Lilly Shares Climb; Morgan Stanley Upgrades Drugmaker to Overweight and Lifts Price TargetBy Rob Lenihan
